http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 27 Aug 2026 07:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Covalon+Reports+Fiscal+2026+Third+Quarter+Results/26984526.html <ul class="bwlistdisc"> <li> <b>Revenue rises 20% year-over-year to over $10.0 million</b> </li> <li> <b>Gross margin expands to 67.2% from 46.5% in the prior year</b> </li> <li> <b>Earnings Per Share of $0.10, more than double the previous quarter</b> </li> <li> <b>Contamination Protection revenue increased 68% year-over-year and 34% over the previous quarter</b> </li> </ul> <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 third quarter results for the period ended June 30, 2026. Full financial statements and management’s discussion and analysis are available on the Company’s profile at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54595362&amp;newsitemid=20260827728715&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=1&amp;md5=d02d8fe3ca904e3a04d58a3a3d61b567" shape="rect">www.sedarplus.ca</a>. </p><p> Brent Ashton, Covalon’s Chief Executive http://www.streetinsider.com/Press+Releases/Covalon+Reports+Fiscal+2026+Third+Quarter+Results/26984526.html Thu, 27 Aug 2026 07:00:00 -0400 A.36078215 COV CVALF O.01582705 O.02555813 http://www.streetinsider.com/Press+Releases/Covalon+Reports+Fiscal+2026+Third+Quarter+Results/26984526.html <ul class="bwlistdisc"> <li> <b>Revenue rises 20% year-over-year to over $10.0 million</b> </li> <li> <b>Gross margin expands to 67.2% from 46.5% in the prior year</b> </li> <li> <b>Earnings Per Share of $0.10, more than double the previous quarter</b> </li> <li> <b>Contamination Protection revenue increased 68% year-over-year and 34% over the previous quarter</b> </li> </ul> <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 third quarter results for the period ended June 30, 2026. Full financial statements and management’s discussion and analysis are available on the Company’s profile at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54595362&amp;newsitemid=20260827728715&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=1&amp;md5=d02d8fe3ca904e3a04d58a3a3d61b567" shape="rect">www.sedarplus.ca</a>. </p><p> Brent Ashton, Covalon’s Chief Executive http://www.streetinsider.com/Press+Releases/Covalon+Reports+Fiscal+2026+Third+Quarter+Results/26984526.html Thu, 27 Aug 2026 07:00:00 -0400 A.36078215 COV CVALF O.01582705 O.02555813 http://www.streetinsider.com/Press+Releases/Covalon+Reports+Fiscal+2026+Third+Quarter+Results/26984526.html <ul class="bwlistdisc"> <li> <b>Revenue rises 20% year-over-year to over $10.0 million</b> </li> <li> <b>Gross margin expands to 67.2% from 46.5% in the prior year</b> </li> <li> <b>Earnings Per Share of $0.10, more than double the previous quarter</b> </li> <li> <b>Contamination Protection revenue increased 68% year-over-year and 34% over the previous quarter</b> </li> </ul> <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 third quarter results for the period ended June 30, 2026. Full financial statements and management’s discussion and analysis are available on the Company’s profile at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54595362&amp;newsitemid=20260827728715&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=1&amp;md5=d02d8fe3ca904e3a04d58a3a3d61b567" shape="rect">www.sedarplus.ca</a>. </p><p> Brent Ashton, Covalon’s Chief Executive http://www.streetinsider.com/Press+Releases/Covalon+Reports+Fiscal+2026+Third+Quarter+Results/26984526.html Thu, 27 Aug 2026 07:00:00 -0400 A.36078215 COV CVALF O.01582705 O.02555813 http://www.streetinsider.com/Press+Releases/Covalon+Reports+Fiscal+2026+Third+Quarter+Results/26984526.html <ul class="bwlistdisc"> <li> <b>Revenue rises 20% year-over-year to over $10.0 million</b> </li> <li> <b>Gross margin expands to 67.2% from 46.5% in the prior year</b> </li> <li> <b>Earnings Per Share of $0.10, more than double the previous quarter</b> </li> <li> <b>Contamination Protection revenue increased 68% year-over-year and 34% over the previous quarter</b> </li> </ul> <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 third quarter results for the period ended June 30, 2026. Full financial statements and management’s discussion and analysis are available on the Company’s profile at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54595362&amp;newsitemid=20260827728715&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=1&amp;md5=d02d8fe3ca904e3a04d58a3a3d61b567" shape="rect">www.sedarplus.ca</a>. </p><p> Brent Ashton, Covalon’s Chief Executive http://www.streetinsider.com/Press+Releases/Covalon+Reports+Fiscal+2026+Third+Quarter+Results/26984526.html Thu, 27 Aug 2026 07:00:00 -0400 A.36078215 COV CVALF O.01582705 O.02555813 http://www.streetinsider.com/Press+Releases/Covalon+Reports+Fiscal+2026+Third+Quarter+Results/26984526.html <ul class="bwlistdisc"> <li> <b>Revenue rises 20% year-over-year to over $10.0 million</b> </li> <li> <b>Gross margin expands to 67.2% from 46.5% in the prior year</b> </li> <li> <b>Earnings Per Share of $0.10, more than double the previous quarter</b> </li> <li> <b>Contamination Protection revenue increased 68% year-over-year and 34% over the previous quarter</b> </li> </ul> <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 third quarter results for the period ended June 30, 2026. Full financial statements and management’s discussion and analysis are available on the Company’s profile at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54595362&amp;newsitemid=20260827728715&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=1&amp;md5=d02d8fe3ca904e3a04d58a3a3d61b567" shape="rect">www.sedarplus.ca</a>. </p><p> Brent Ashton, Covalon’s Chief Executive http://www.streetinsider.com/Press+Releases/Covalon+Reports+Fiscal+2026+Third+Quarter+Results/26984526.html Thu, 27 Aug 2026 07:00:00 -0400 A.36078215 COV CVALF O.01582705 O.02555813 http://www.streetinsider.com/Business+Wire/Covalon+Reports+Fiscal+2026+Third+Quarter+Results/26984526.html <ul class="bwlistdisc"> <li> <b>Revenue rises 20% year-over-year to over $10.0 million</b> </li> <li> <b>Gross margin expands to 67.2% from 46.5% in the prior year</b> </li> <li> <b>Earnings Per Share of $0.10, more than double the previous quarter</b> </li> <li> <b>Contamination Protection revenue increased 68% year-over-year and 34% over the previous quarter</b> </li> </ul> <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 third quarter results for the period ended June 30, 2026. Full financial statements and management’s discussion and analysis are available on the Company’s profile at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54595362&amp;newsitemid=20260827728715&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=1&amp;md5=d02d8fe3ca904e3a04d58a3a3d61b567" shape="rect">www.sedarplus.ca</a>. </p><p> Brent Ashton, Covalon’s Chief Executive http://www.streetinsider.com/Business+Wire/Covalon+Reports+Fiscal+2026+Third+Quarter+Results/26984526.html Thu, 27 Aug 2026 07:00:00 -0400 A.36078215 COV CVALF O.01582705 O.02555813 http://www.streetinsider.com/Business+Wire/Covalon+Reports+Fiscal+2026+Third+Quarter+Results/26984526.html <ul class="bwlistdisc"> <li> <b>Revenue rises 20% year-over-year to over $10.0 million</b> </li> <li> <b>Gross margin expands to 67.2% from 46.5% in the prior year</b> </li> <li> <b>Earnings Per Share of $0.10, more than double the previous quarter</b> </li> <li> <b>Contamination Protection revenue increased 68% year-over-year and 34% over the previous quarter</b> </li> </ul> <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 third quarter results for the period ended June 30, 2026. Full financial statements and management’s discussion and analysis are available on the Company’s profile at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54595362&amp;newsitemid=20260827728715&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=1&amp;md5=d02d8fe3ca904e3a04d58a3a3d61b567" shape="rect">www.sedarplus.ca</a>. </p><p> Brent Ashton, Covalon’s Chief Executive http://www.streetinsider.com/Business+Wire/Covalon+Reports+Fiscal+2026+Third+Quarter+Results/26984526.html Thu, 27 Aug 2026 07:00:00 -0400 A.36078215 COV CVALF O.01582705 O.02555813 http://www.streetinsider.com/Business+Wire/Covalon+Reports+Fiscal+2026+Third+Quarter+Results/26984526.html <ul class="bwlistdisc"> <li> <b>Revenue rises 20% year-over-year to over $10.0 million</b> </li> <li> <b>Gross margin expands to 67.2% from 46.5% in the prior year</b> </li> <li> <b>Earnings Per Share of $0.10, more than double the previous quarter</b> </li> <li> <b>Contamination Protection revenue increased 68% year-over-year and 34% over the previous quarter</b> </li> </ul> <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 third quarter results for the period ended June 30, 2026. Full financial statements and management’s discussion and analysis are available on the Company’s profile at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54595362&amp;newsitemid=20260827728715&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=1&amp;md5=d02d8fe3ca904e3a04d58a3a3d61b567" shape="rect">www.sedarplus.ca</a>. </p><p> Brent Ashton, Covalon’s Chief Executive http://www.streetinsider.com/Business+Wire/Covalon+Reports+Fiscal+2026+Third+Quarter+Results/26984526.html Thu, 27 Aug 2026 07:00:00 -0400 A.36078215 COV CVALF O.01582705 O.02555813 http://www.streetinsider.com/Business+Wire/Covalon+Reports+Fiscal+2026+Third+Quarter+Results/26984526.html <ul class="bwlistdisc"> <li> <b>Revenue rises 20% year-over-year to over $10.0 million</b> </li> <li> <b>Gross margin expands to 67.2% from 46.5% in the prior year</b> </li> <li> <b>Earnings Per Share of $0.10, more than double the previous quarter</b> </li> <li> <b>Contamination Protection revenue increased 68% year-over-year and 34% over the previous quarter</b> </li> </ul> <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 third quarter results for the period ended June 30, 2026. Full financial statements and management’s discussion and analysis are available on the Company’s profile at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54595362&amp;newsitemid=20260827728715&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=1&amp;md5=d02d8fe3ca904e3a04d58a3a3d61b567" shape="rect">www.sedarplus.ca</a>. </p><p> Brent Ashton, Covalon’s Chief Executive http://www.streetinsider.com/Business+Wire/Covalon+Reports+Fiscal+2026+Third+Quarter+Results/26984526.html Thu, 27 Aug 2026 07:00:00 -0400 A.36078215 COV CVALF O.01582705 O.02555813 http://www.streetinsider.com/Business+Wire/Covalon+Reports+Fiscal+2026+Third+Quarter+Results/26984526.html <ul class="bwlistdisc"> <li> <b>Revenue rises 20% year-over-year to over $10.0 million</b> </li> <li> <b>Gross margin expands to 67.2% from 46.5% in the prior year</b> </li> <li> <b>Earnings Per Share of $0.10, more than double the previous quarter</b> </li> <li> <b>Contamination Protection revenue increased 68% year-over-year and 34% over the previous quarter</b> </li> </ul> <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 third quarter results for the period ended June 30, 2026. Full financial statements and management’s discussion and analysis are available on the Company’s profile at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54595362&amp;newsitemid=20260827728715&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=1&amp;md5=d02d8fe3ca904e3a04d58a3a3d61b567" shape="rect">www.sedarplus.ca</a>. </p><p> Brent Ashton, Covalon’s Chief Executive http://www.streetinsider.com/Business+Wire/Covalon+Reports+Fiscal+2026+Third+Quarter+Results/26984526.html Thu, 27 Aug 2026 07:00:00 -0400 A.36078215 COV CVALF O.01582705 O.02555813 http://www.streetinsider.com/Press+Releases/Covalon+Announces+Conference+Call+to+Discuss+Third+Quarter+Fiscal+2026+Results/26952584.html <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q3 Fiscal 2026 results on Thursday, August 27, 2026, before markets open. A conference call and webcast to discuss the results will be held on Thursday, August 27, 2026, at 8:30am ET. </p><p> To view, listen to, and participate in the live webcast, please follow the link below: </p><p class="bwalignc"> <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fevents.q4inc.com%2Fattendee%2F768174807&amp;esheet=54592169&amp;newsitemid=20260820995279&amp;lan=en-US&amp;anchor=https%3A%2F%2Fevents.q4inc.com%2Fattendee%2F768174807&amp;index=1&amp;md5=70d351f154d433cea6622c36f4b4d3d3" shape="rect">https://events.q4inc.com/attendee/768174807</a> </p><p> To listen and participate via the conference call, please dial: </p><p class="bwalignc"> North America Toll-Free: 1-833-461-5787 <br />International Toll: 1-585-542-9983 <br />International Dial-Ins: <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fhelp.events.q4inc.com%2Feahc%2Finternational-dial-in-numbers&amp;esheet=54592169&amp;newsitemid=20260820995279&amp;lan=en-US&amp;anchor=https%3A%2F%2Fhelp.events.q4inc.com%2Feahc%2Finternational-dial-in-numbers&amp;index=2&amp;md5=a8aaa18a8d557d04e31916084663f0f2" shape="rect">https://help.events.q4inc.com/eahc/international-dial-in-numbers </a><br />Meeting http://www.streetinsider.com/Press+Releases/Covalon+Announces+Conference+Call+to+Discuss+Third+Quarter+Fiscal+2026+Results/26952584.html Thu, 20 Aug 2026 07:00:00 -0400 COV CVALF O.01582705 http://www.streetinsider.com/Press+Releases/Covalon+Announces+Conference+Call+to+Discuss+Third+Quarter+Fiscal+2026+Results/26952584.html <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q3 Fiscal 2026 results on Thursday, August 27, 2026, before markets open. A conference call and webcast to discuss the results will be held on Thursday, August 27, 2026, at 8:30am ET. </p><p> To view, listen to, and participate in the live webcast, please follow the link below: </p><p class="bwalignc"> <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fevents.q4inc.com%2Fattendee%2F768174807&amp;esheet=54592169&amp;newsitemid=20260820995279&amp;lan=en-US&amp;anchor=https%3A%2F%2Fevents.q4inc.com%2Fattendee%2F768174807&amp;index=1&amp;md5=70d351f154d433cea6622c36f4b4d3d3" shape="rect">https://events.q4inc.com/attendee/768174807</a> </p><p> To listen and participate via the conference call, please dial: </p><p class="bwalignc"> North America Toll-Free: 1-833-461-5787 <br />International Toll: 1-585-542-9983 <br />International Dial-Ins: <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fhelp.events.q4inc.com%2Feahc%2Finternational-dial-in-numbers&amp;esheet=54592169&amp;newsitemid=20260820995279&amp;lan=en-US&amp;anchor=https%3A%2F%2Fhelp.events.q4inc.com%2Feahc%2Finternational-dial-in-numbers&amp;index=2&amp;md5=a8aaa18a8d557d04e31916084663f0f2" shape="rect">https://help.events.q4inc.com/eahc/international-dial-in-numbers </a><br />Meeting http://www.streetinsider.com/Press+Releases/Covalon+Announces+Conference+Call+to+Discuss+Third+Quarter+Fiscal+2026+Results/26952584.html Thu, 20 Aug 2026 07:00:00 -0400 COV CVALF O.01582705 http://www.streetinsider.com/Press+Releases/Covalon+Announces+Conference+Call+to+Discuss+Third+Quarter+Fiscal+2026+Results/26952584.html <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q3 Fiscal 2026 results on Thursday, August 27, 2026, before markets open. A conference call and webcast to discuss the results will be held on Thursday, August 27, 2026, at 8:30am ET. </p><p> To view, listen to, and participate in the live webcast, please follow the link below: </p><p class="bwalignc"> <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fevents.q4inc.com%2Fattendee%2F768174807&amp;esheet=54592169&amp;newsitemid=20260820995279&amp;lan=en-US&amp;anchor=https%3A%2F%2Fevents.q4inc.com%2Fattendee%2F768174807&amp;index=1&amp;md5=70d351f154d433cea6622c36f4b4d3d3" shape="rect">https://events.q4inc.com/attendee/768174807</a> </p><p> To listen and participate via the conference call, please dial: </p><p class="bwalignc"> North America Toll-Free: 1-833-461-5787 <br />International Toll: 1-585-542-9983 <br />International Dial-Ins: <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fhelp.events.q4inc.com%2Feahc%2Finternational-dial-in-numbers&amp;esheet=54592169&amp;newsitemid=20260820995279&amp;lan=en-US&amp;anchor=https%3A%2F%2Fhelp.events.q4inc.com%2Feahc%2Finternational-dial-in-numbers&amp;index=2&amp;md5=a8aaa18a8d557d04e31916084663f0f2" shape="rect">https://help.events.q4inc.com/eahc/international-dial-in-numbers </a><br />Meeting http://www.streetinsider.com/Press+Releases/Covalon+Announces+Conference+Call+to+Discuss+Third+Quarter+Fiscal+2026+Results/26952584.html Thu, 20 Aug 2026 07:00:00 -0400 COV CVALF O.01582705 http://www.streetinsider.com/Business+Wire/Covalon+Announces+Conference+Call+to+Discuss+Third+Quarter+Fiscal+2026+Results/26952584.html <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q3 Fiscal 2026 results on Thursday, August 27, 2026, before markets open. A conference call and webcast to discuss the results will be held on Thursday, August 27, 2026, at 8:30am ET. </p><p> To view, listen to, and participate in the live webcast, please follow the link below: </p><p class="bwalignc"> <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fevents.q4inc.com%2Fattendee%2F768174807&amp;esheet=54592169&amp;newsitemid=20260820995279&amp;lan=en-US&amp;anchor=https%3A%2F%2Fevents.q4inc.com%2Fattendee%2F768174807&amp;index=1&amp;md5=70d351f154d433cea6622c36f4b4d3d3" shape="rect">https://events.q4inc.com/attendee/768174807</a> </p><p> To listen and participate via the conference call, please dial: </p><p class="bwalignc"> North America Toll-Free: 1-833-461-5787 <br />International Toll: 1-585-542-9983 <br />International Dial-Ins: <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fhelp.events.q4inc.com%2Feahc%2Finternational-dial-in-numbers&amp;esheet=54592169&amp;newsitemid=20260820995279&amp;lan=en-US&amp;anchor=https%3A%2F%2Fhelp.events.q4inc.com%2Feahc%2Finternational-dial-in-numbers&amp;index=2&amp;md5=a8aaa18a8d557d04e31916084663f0f2" shape="rect">https://help.events.q4inc.com/eahc/international-dial-in-numbers </a><br />Meeting http://www.streetinsider.com/Business+Wire/Covalon+Announces+Conference+Call+to+Discuss+Third+Quarter+Fiscal+2026+Results/26952584.html Thu, 20 Aug 2026 07:00:00 -0400 COV CVALF O.01582705 http://www.streetinsider.com/Business+Wire/Covalon+Announces+Conference+Call+to+Discuss+Third+Quarter+Fiscal+2026+Results/26952584.html <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q3 Fiscal 2026 results on Thursday, August 27, 2026, before markets open. A conference call and webcast to discuss the results will be held on Thursday, August 27, 2026, at 8:30am ET. </p><p> To view, listen to, and participate in the live webcast, please follow the link below: </p><p class="bwalignc"> <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fevents.q4inc.com%2Fattendee%2F768174807&amp;esheet=54592169&amp;newsitemid=20260820995279&amp;lan=en-US&amp;anchor=https%3A%2F%2Fevents.q4inc.com%2Fattendee%2F768174807&amp;index=1&amp;md5=70d351f154d433cea6622c36f4b4d3d3" shape="rect">https://events.q4inc.com/attendee/768174807</a> </p><p> To listen and participate via the conference call, please dial: </p><p class="bwalignc"> North America Toll-Free: 1-833-461-5787 <br />International Toll: 1-585-542-9983 <br />International Dial-Ins: <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fhelp.events.q4inc.com%2Feahc%2Finternational-dial-in-numbers&amp;esheet=54592169&amp;newsitemid=20260820995279&amp;lan=en-US&amp;anchor=https%3A%2F%2Fhelp.events.q4inc.com%2Feahc%2Finternational-dial-in-numbers&amp;index=2&amp;md5=a8aaa18a8d557d04e31916084663f0f2" shape="rect">https://help.events.q4inc.com/eahc/international-dial-in-numbers </a><br />Meeting http://www.streetinsider.com/Business+Wire/Covalon+Announces+Conference+Call+to+Discuss+Third+Quarter+Fiscal+2026+Results/26952584.html Thu, 20 Aug 2026 07:00:00 -0400 COV CVALF O.01582705 http://www.streetinsider.com/Business+Wire/Covalon+Announces+Conference+Call+to+Discuss+Third+Quarter+Fiscal+2026+Results/26952584.html <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q3 Fiscal 2026 results on Thursday, August 27, 2026, before markets open. A conference call and webcast to discuss the results will be held on Thursday, August 27, 2026, at 8:30am ET. </p><p> To view, listen to, and participate in the live webcast, please follow the link below: </p><p class="bwalignc"> <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fevents.q4inc.com%2Fattendee%2F768174807&amp;esheet=54592169&amp;newsitemid=20260820995279&amp;lan=en-US&amp;anchor=https%3A%2F%2Fevents.q4inc.com%2Fattendee%2F768174807&amp;index=1&amp;md5=70d351f154d433cea6622c36f4b4d3d3" shape="rect">https://events.q4inc.com/attendee/768174807</a> </p><p> To listen and participate via the conference call, please dial: </p><p class="bwalignc"> North America Toll-Free: 1-833-461-5787 <br />International Toll: 1-585-542-9983 <br />International Dial-Ins: <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fhelp.events.q4inc.com%2Feahc%2Finternational-dial-in-numbers&amp;esheet=54592169&amp;newsitemid=20260820995279&amp;lan=en-US&amp;anchor=https%3A%2F%2Fhelp.events.q4inc.com%2Feahc%2Finternational-dial-in-numbers&amp;index=2&amp;md5=a8aaa18a8d557d04e31916084663f0f2" shape="rect">https://help.events.q4inc.com/eahc/international-dial-in-numbers </a><br />Meeting http://www.streetinsider.com/Business+Wire/Covalon+Announces+Conference+Call+to+Discuss+Third+Quarter+Fiscal+2026+Results/26952584.html Thu, 20 Aug 2026 07:00:00 -0400 COV CVALF O.01582705 http://www.streetinsider.com/Board+Changes/Covalon+appoints+Dr.+Murray+Miller+to+board%2C+grants+DSUs/26622767.html <p>Covalon Technologies Ltd. (TSXV: COV; OTCQX: CVALF) announced the appointment of Dr. Murray Miller to its board of directors as an independent director, subject to TSX Venture Exchange approval.</p> <p>Dr. Miller graduated as a medical doctor from the University of Manitoba in 1982 and completed his residency in radiology at the University of Toronto. He has served as a physician and practice leader at Ontario hospitals and community clinics and has held leadership positions in medical associations while advising biotech and medical technology companies.</p> <p>Dr. Miller previously served on Covalon's board from 2010 to 2019 and remains a shareholder of the company. http://www.streetinsider.com/Board+Changes/Covalon+appoints+Dr.+Murray+Miller+to+board%2C+grants+DSUs/26622767.html Tue, 09 Jun 2026 13:00:20 -0400 A.07459108 A.36078215 A.60012013 COV CVALF O.01582705 O.02555813 O.02561070 O.54379156 http://www.streetinsider.com/Board+Changes/Covalon+appoints+Dr.+Murray+Miller+to+board%2C+grants+DSUs/26622767.html <p>Covalon Technologies Ltd. (TSXV: COV; OTCQX: CVALF) announced the appointment of Dr. Murray Miller to its board of directors as an independent director, subject to TSX Venture Exchange approval.</p> <p>Dr. Miller graduated as a medical doctor from the University of Manitoba in 1982 and completed his residency in radiology at the University of Toronto. He has served as a physician and practice leader at Ontario hospitals and community clinics and has held leadership positions in medical associations while advising biotech and medical technology companies.</p> <p>Dr. Miller previously served on Covalon's board from 2010 to 2019 and remains a shareholder of the company. http://www.streetinsider.com/Board+Changes/Covalon+appoints+Dr.+Murray+Miller+to+board%2C+grants+DSUs/26622767.html Tue, 09 Jun 2026 13:00:20 -0400 A.07459108 A.36078215 A.60012013 COV CVALF O.01582705 O.02555813 O.02561070 O.54379156 http://www.streetinsider.com/Board+Changes/Covalon+appoints+Dr.+Murray+Miller+to+board%2C+grants+DSUs/26622767.html <p>Covalon Technologies Ltd. (TSXV: COV; OTCQX: CVALF) announced the appointment of Dr. Murray Miller to its board of directors as an independent director, subject to TSX Venture Exchange approval.</p> <p>Dr. Miller graduated as a medical doctor from the University of Manitoba in 1982 and completed his residency in radiology at the University of Toronto. He has served as a physician and practice leader at Ontario hospitals and community clinics and has held leadership positions in medical associations while advising biotech and medical technology companies.</p> <p>Dr. Miller previously served on Covalon's board from 2010 to 2019 and remains a shareholder of the company. http://www.streetinsider.com/Board+Changes/Covalon+appoints+Dr.+Murray+Miller+to+board%2C+grants+DSUs/26622767.html Tue, 09 Jun 2026 13:00:20 -0400 A.07459108 A.36078215 A.60012013 COV CVALF O.01582705 O.02555813 O.02561070 O.54379156 http://www.streetinsider.com/Board+Changes/Covalon+appoints+Dr.+Murray+Miller+to+board%2C+grants+DSUs/26622767.html <p>Covalon Technologies Ltd. (TSXV: COV; OTCQX: CVALF) announced the appointment of Dr. Murray Miller to its board of directors as an independent director, subject to TSX Venture Exchange approval.</p> <p>Dr. Miller graduated as a medical doctor from the University of Manitoba in 1982 and completed his residency in radiology at the University of Toronto. He has served as a physician and practice leader at Ontario hospitals and community clinics and has held leadership positions in medical associations while advising biotech and medical technology companies.</p> <p>Dr. Miller previously served on Covalon's board from 2010 to 2019 and remains a shareholder of the company. http://www.streetinsider.com/Board+Changes/Covalon+appoints+Dr.+Murray+Miller+to+board%2C+grants+DSUs/26622767.html Tue, 09 Jun 2026 13:00:20 -0400 A.07459108 A.36078215 A.60012013 COV CVALF O.01582705 O.02555813 O.02561070 O.54379156 http://www.streetinsider.com/Board+Changes/Covalon+appoints+Dr.+Murray+Miller+to+board%2C+grants+DSUs/26622767.html <p>Covalon Technologies Ltd. (TSXV: COV; OTCQX: CVALF) announced the appointment of Dr. Murray Miller to its board of directors as an independent director, subject to TSX Venture Exchange approval.</p> <p>Dr. Miller graduated as a medical doctor from the University of Manitoba in 1982 and completed his residency in radiology at the University of Toronto. He has served as a physician and practice leader at Ontario hospitals and community clinics and has held leadership positions in medical associations while advising biotech and medical technology companies.</p> <p>Dr. Miller previously served on Covalon's board from 2010 to 2019 and remains a shareholder of the company. http://www.streetinsider.com/Board+Changes/Covalon+appoints+Dr.+Murray+Miller+to+board%2C+grants+DSUs/26622767.html Tue, 09 Jun 2026 13:00:20 -0400 A.07459108 A.36078215 A.60012013 COV CVALF O.01582705 O.02555813 O.02561070 O.54379156 http://www.streetinsider.com/Board+Changes/Covalon+appoints+Dr.+Murray+Miller+to+board%2C+grants+DSUs/26622767.html <p>Covalon Technologies Ltd. (TSXV: COV; OTCQX: CVALF) announced the appointment of Dr. Murray Miller to its board of directors as an independent director, subject to TSX Venture Exchange approval.</p> <p>Dr. Miller graduated as a medical doctor from the University of Manitoba in 1982 and completed his residency in radiology at the University of Toronto. He has served as a physician and practice leader at Ontario hospitals and community clinics and has held leadership positions in medical associations while advising biotech and medical technology companies.</p> <p>Dr. Miller previously served on Covalon's board from 2010 to 2019 and remains a shareholder of the company. http://www.streetinsider.com/Board+Changes/Covalon+appoints+Dr.+Murray+Miller+to+board%2C+grants+DSUs/26622767.html Tue, 09 Jun 2026 13:00:20 -0400 A.07459108 A.36078215 A.60012013 COV CVALF O.01582705 O.02555813 O.02561070 O.54379156 http://www.streetinsider.com/Board+Changes/Covalon+appoints+Dr.+Murray+Miller+to+board%2C+grants+DSUs/26622767.html <p>Covalon Technologies Ltd. (TSXV: COV; OTCQX: CVALF) announced the appointment of Dr. Murray Miller to its board of directors as an independent director, subject to TSX Venture Exchange approval.</p> <p>Dr. Miller graduated as a medical doctor from the University of Manitoba in 1982 and completed his residency in radiology at the University of Toronto. He has served as a physician and practice leader at Ontario hospitals and community clinics and has held leadership positions in medical associations while advising biotech and medical technology companies.</p> <p>Dr. Miller previously served on Covalon's board from 2010 to 2019 and remains a shareholder of the company. http://www.streetinsider.com/Board+Changes/Covalon+appoints+Dr.+Murray+Miller+to+board%2C+grants+DSUs/26622767.html Tue, 09 Jun 2026 13:00:20 -0400 A.07459108 A.36078215 A.60012013 COV CVALF O.01582705 O.02555813 O.02561070 O.54379156 http://www.streetinsider.com/Board+Changes/Covalon+appoints+Dr.+Murray+Miller+to+board%2C+grants+DSUs/26622767.html <p>Covalon Technologies Ltd. (TSXV: COV; OTCQX: CVALF) announced the appointment of Dr. Murray Miller to its board of directors as an independent director, subject to TSX Venture Exchange approval.</p> <p>Dr. Miller graduated as a medical doctor from the University of Manitoba in 1982 and completed his residency in radiology at the University of Toronto. He has served as a physician and practice leader at Ontario hospitals and community clinics and has held leadership positions in medical associations while advising biotech and medical technology companies.</p> <p>Dr. Miller previously served on Covalon's board from 2010 to 2019 and remains a shareholder of the company. http://www.streetinsider.com/Board+Changes/Covalon+appoints+Dr.+Murray+Miller+to+board%2C+grants+DSUs/26622767.html Tue, 09 Jun 2026 13:00:20 -0400 A.07459108 A.36078215 A.60012013 COV CVALF O.01582705 O.02555813 O.02561070 O.54379156 http://www.streetinsider.com/Board+Changes/Covalon+appoints+Dr.+Murray+Miller+to+board%2C+grants+DSUs/26622767.html <p>Covalon Technologies Ltd. (TSXV: COV; OTCQX: CVALF) announced the appointment of Dr. Murray Miller to its board of directors as an independent director, subject to TSX Venture Exchange approval.</p> <p>Dr. Miller graduated as a medical doctor from the University of Manitoba in 1982 and completed his residency in radiology at the University of Toronto. He has served as a physician and practice leader at Ontario hospitals and community clinics and has held leadership positions in medical associations while advising biotech and medical technology companies.</p> <p>Dr. Miller previously served on Covalon's board from 2010 to 2019 and remains a shareholder of the company. http://www.streetinsider.com/Board+Changes/Covalon+appoints+Dr.+Murray+Miller+to+board%2C+grants+DSUs/26622767.html Tue, 09 Jun 2026 13:00:20 -0400 A.07459108 A.36078215 A.60012013 COV CVALF O.01582705 O.02555813 O.02561070 O.54379156